{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:01:27Z","timestamp":1792425687700,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.intimp.2024.112323","type":"journal-article","created":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T19:27:14Z","timestamp":1716492434000},"page":"112323","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["The hidden dangers of short-term glucocorticoid use in children: A genomic analysis"],"prefix":"10.1016","volume":"135","author":[{"given":"Xiaolin","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongxin","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinwen","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0442-1412","authenticated-orcid":false,"given":"Huawei","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.intimp.2024.112323_b0005","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2344\/0003-3006-60.1.25","article-title":"Basic and clinical pharmacology of glucocorticosteroids","volume":"60","author":"Becker","year":"2013","journal-title":"Anesth. Prog."},{"issue":"20","key":"10.1016\/j.intimp.2024.112323_b0010","doi-asserted-by":"crossref","first-page":"5032","DOI":"10.1016\/j.bmcl.2016.08.091","article-title":"Novel selective glucocorticoid receptor agonists (SEGRAs) with a covalent warhead for long-lasting inhibition","volume":"26","author":"Ryabtsova","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.intimp.2024.112323_b0015","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000342502","article-title":"Exploring the molecular mechanisms of glucocorticoid receptor action from sensitivity to resistance","volume":"24","author":"Ramamoorthy","year":"2013","journal-title":"Endocr. Dev."},{"issue":"1","key":"10.1016\/j.intimp.2024.112323_b0020","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jaad.2016.02.1239","article-title":"Prevention and management of glucocorticoid-induced side effects: A comprehensive review: Gastrointestinal and endocrinologic side effects","volume":"76","author":"Caplan","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.intimp.2024.112323_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105189","article-title":"Why do some asthma patients respond poorly to glucocorticoid therapy?","volume":"160","author":"Henderson","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"3","key":"10.1016\/j.intimp.2024.112323_b0030","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1136\/ard.2005.038638","article-title":"Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data","volume":"65","author":"Da Silva","year":"2006","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.intimp.2024.112323_b0035","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1111\/all.14552","article-title":"Combined analysis of transcriptomic and genetic data for the identification of loci involved in glucocorticosteroid response in asthma","volume":"76","author":"Hernandez-Pacheco","year":"2021","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.intimp.2024.112323_b0040","doi-asserted-by":"crossref","first-page":"417","DOI":"10.5114\/aoms.2019.84470","article-title":"NGS study of glucocorticoid response genes in inflammatory bowel disease patients","volume":"17","author":"Skrzypczak-Zielinska","year":"2019","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.intimp.2024.112323_b0045","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.gene.2018.05.091","article-title":"The pathogenesis of steroid-induced osteonecrosis of the femoral head: A systematic review of the literature","volume":"671","author":"Wang","year":"2018","journal-title":"Gene"},{"issue":"2","key":"10.1016\/j.intimp.2024.112323_b0050","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.thromres.2013.06.023","article-title":"Association between PAI-1 4G\/5G Polymorphisms and osteonecrosis of femoral head: a meta-analysis","volume":"132","author":"Liang","year":"2013","journal-title":"Thromb. Res."},{"key":"10.1016\/j.intimp.2024.112323_b0055","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.3389\/fphys.2018.01684","article-title":"Lipid transporter activity-related genetic polymorphisms are associated with steroid-induced osteonecrosis of the femoral head: an updated meta-analysis based on the GRADE guidelines","volume":"9","author":"Chen","year":"2018","journal-title":"Front. Physiol."},{"issue":"4","key":"10.1016\/j.intimp.2024.112323_b0060","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/86882","article-title":"Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression","volume":"27","author":"Kuehl","year":"2001","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.intimp.2024.112323_b0065","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/cpt.350","article-title":"Genetic variation among 82 pharmacogenes: The PGRNseq data from the eMERGE network","volume":"100","author":"Bush","year":"2016","journal-title":"Clin. Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.intimp.2024.112323_b0070","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2217\/pgs-2019-0153","article-title":"Evaluation of clinical impact of pharmacogenomics knowledge involved in CPIC guidelines on Chinese pediatric patients","volume":"21","author":"Qin","year":"2020","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.intimp.2024.112323_b0075","first-page":"1041","article-title":"Inferring ADR causality by predicting the Naranjo Score from Clinical Notes","volume":"2020","author":"Rawat","year":"2021","journal-title":"AMIA Annu. Symp. Proc."},{"issue":"2","key":"10.1016\/j.intimp.2024.112323_b0080","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a033027","article-title":"The role of next-generation sequencing in pharmacogenetics and pharmacogenomics","volume":"9","author":"Schwarz","year":"2019","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"10","key":"10.1016\/j.intimp.2024.112323_b0085","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1111\/1759-7714.13589","article-title":"Use of glucocorticoids in the management of immunotherapy-related adverse effects","volume":"11","author":"Wang","year":"2020","journal-title":"Thorac Cancer."},{"issue":"12","key":"10.1016\/j.intimp.2024.112323_b0090","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1089\/gtmb.2020.0201","article-title":"Association of ABCB1 and CYP450 gene polymorphisms and their DNA methylation status with steroid-induced osteonecrosis of the femoral head in the Chinese population","volume":"24","author":"Huang","year":"2020","journal-title":"Genet. Test. Mol. Biomarkers"},{"issue":"4","key":"10.1016\/j.intimp.2024.112323_b0095","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.steroids.2013.01.004","article-title":"Genetic risk factors for glucocorticoid-induced osteonecrosis: a meta-analysis","volume":"78","author":"Gong","year":"2013","journal-title":"Steroids"},{"issue":"1","key":"10.1016\/j.intimp.2024.112323_b0100","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.gene.2015.03.023","article-title":"Association of ABCB1\/MDR1 polymorphisms in patients with glucocorticoid-induced osteonecrosis of the femoral head: Evidence for a meta-analysis","volume":"569","author":"Zhou","year":"2015","journal-title":"Gene"},{"key":"10.1016\/j.intimp.2024.112323_b0105","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.12659\/MSM.891286","article-title":"ABCB1 gene polymorphisms and glucocorticoid-induced avascular necrosis of the femoral head susceptibility: a meta-analysis","volume":"20","author":"Li","year":"2014","journal-title":"Med. Sci. Monit."},{"issue":"2","key":"10.1016\/j.intimp.2024.112323_b0110","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1080\/08941939.2017.1385663","article-title":"Correlation between steroid-induced osteonecrosis of the femoral head and hepatic CYP3A activity: a systematic review and meta-analysis","volume":"32","author":"Guo","year":"2019","journal-title":"J. Invest. Surg."},{"issue":"5","key":"10.1016\/j.intimp.2024.112323_b0115","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1007\/s11033-014-3173-y","article-title":"Genetic association of the P-glycoprotein gene ABCB1 polymorphisms with the risk for steroid-induced osteonecrosis of the femoral head in Chinese population","volume":"41","author":"Zhang","year":"2014","journal-title":"Mol. Biol. Rep."},{"issue":"11","key":"10.1016\/j.intimp.2024.112323_b0120","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/00008571-200311000-00003","article-title":"ABCB1 C3435T and G2677T\/A polymorphism decreased the risk for steroid-induced osteonecrosis of the femoral head after kidney transplantation","volume":"13","author":"Asano","year":"2003","journal-title":"Pharmacogenetics"},{"issue":"6","key":"10.1016\/j.intimp.2024.112323_b0125","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1042\/BST20180146","article-title":"Substrate polyspecificity and conformational relevance in ABC transporters: new insights from structural studies","volume":"46","author":"Wright","year":"2018","journal-title":"Biochem. Soc. Trans."},{"issue":"4","key":"10.1016\/j.intimp.2024.112323_b0130","first-page":"15","article-title":"A case of high-risk factors","volume":"28","author":"Beibei","year":"2022","journal-title":"J. Pediatr. Pharm."},{"issue":"1","key":"10.1016\/j.intimp.2024.112323_b0135","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1186\/s13287-020-01991-2","article-title":"Bone marrow mesenchymal stem cell-derived exosomes promote plasminogen activator inhibitor 1 expression in vascular cells in the local microenvironment during rabbit osteonecrosis of the femoral head","volume":"11","author":"Li","year":"2020","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.intimp.2024.112323_b0140","first-page":"1364","article-title":"The correlation between apolipoprotein gene polymorphisms and steroid- induced osteonecrosis of the femoral head","volume":"36","author":"Wei","year":"2015","journal-title":"Guangdong Med. J."},{"key":"10.1016\/j.intimp.2024.112323_b0145","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/1746-1596-8-169","article-title":"Genetic polymorphisms in plasminogen activator inhibitor-1 predict susceptibility to steroid-induced osteonecrosis of the femoral head in Chinese population","volume":"8","author":"Zhang","year":"2013","journal-title":"Diagn. Pathol."},{"issue":"2","key":"10.1016\/j.intimp.2024.112323_b0150","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/nep.12353","article-title":"Macrophage migration inhibitory factor -173G\/C gene polymorphism increases the risk of renal disease: a meta-analysis","volume":"20","author":"Tong","year":"2015","journal-title":"Nephrology (Carlton)"},{"issue":"3","key":"10.1016\/j.intimp.2024.112323_b0155","first-page":"516","article-title":"Low molecular weight phenotype of Apo(a) is a risk factor of corticosteroid-induced osteonecrosis of the femoral head after renal transplant","volume":"34","author":"Hirata","year":"2007","journal-title":"J. Rheumatol."},{"issue":"1","key":"10.1016\/j.intimp.2024.112323_b0160","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s13018-022-03079-4","article-title":"Integrative analyses of genes related to femoral head osteonecrosis: an umbrella review of systematic reviews and meta-analyses of observational studies","volume":"17","author":"Lee","year":"2022","journal-title":"J. Orthop. Surg. Res."},{"issue":"4","key":"10.1016\/j.intimp.2024.112323_b0165","doi-asserted-by":"crossref","first-page":"25","DOI":"10.53388\/CRC2023025","article-title":"Factors influencing medication literacy in Chinese children with nephrotic syndrome: insights from the MLS-22 scale","volume":"6","author":"Xu","year":"2023","journal-title":"Clin Res Commun."},{"issue":"5","key":"10.1016\/j.intimp.2024.112323_b0170","doi-asserted-by":"crossref","first-page":"434","DOI":"10.6002\/ect.2021.0101","article-title":"Frequency of ABCB1 C3435T and CYP3A5*3 genetic polymorphisms in the Lebanese population","volume":"19","author":"Milane","year":"2021","journal-title":"Exp. Clin. Transplant."},{"key":"10.1016\/j.intimp.2024.112323_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112083","article-title":"ABCB1 C3435T, G2677T\/A and C1236T variants have no effect in eslicarbazepine pharmacokinetics","volume":"142","author":"Zubiaur","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.intimp.2024.112323_b0180","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1186\/s13104-021-05711-8","article-title":"Genetic variation of ABCB1 (rs1128503, rs1045642) and CYP2E1 rs3813867 with the duration of tuberculosis therapy: a pilot study among tuberculosis patients in Indonesia","volume":"14","author":"Barliana","year":"2021","journal-title":"BMC Res. Notes"},{"issue":"4","key":"10.1016\/j.intimp.2024.112323_b0185","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.31557\/APJCP.2024.25.4.1391","article-title":"Efficacy and toxicity of vincristine and CYP3A5 genetic polymorphism in rhabdomyosarcoma pediatric egyptian patients","volume":"25","author":"Shalaby","year":"2024","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"8","key":"10.1016\/j.intimp.2024.112323_b0190","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3109\/08916934.2013.830714","article-title":"Association study of glucocorticoid receptor genetic polymorphisms with efficacy of glucocorticoids in systemic lupus erythematosus: a prospective cohort study","volume":"46","author":"Zou","year":"2013","journal-title":"Autoimmunity"},{"issue":"12","key":"10.1016\/j.intimp.2024.112323_b0195","first-page":"2793","article-title":"CYP450 gene polymorphism of children in Chongqing","volume":"41","author":"Xiaoli","year":"2021","journal-title":"J. Clin. Pathol. Res."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924008439?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924008439?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T08:15:55Z","timestamp":1717661755000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924008439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":39,"alternative-id":["S1567576924008439"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112323","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The hidden dangers of short-term glucocorticoid use in children: A genomic analysis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112323","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112323"}}